Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.
If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-778-2778. It is possible to get an appointment for a second opinion within a few days of contacting us.
We hope you find the information helpful!
|Forum||Questions||Ask a Question|
|Metastatic Breast Cancer
Questions about advanced metastatic breast cancer.
|Asked||Publicly Submitted Question|
|11/1/2005||I am 34 with stage 4 breast cancer with lung and bone mets. The bone mets consists of 3 small rib lesions. I am currently being treated with lupron,tamoxifen,herceptin and zometa. Much of the bone pain has subsided and my ca2729 has been dropping over the past 3 months with a ct scan showing some improvement. My question is, if the bone mets are destroyed is there any reason to continue the zometa treatment? (Calcium level has always been normal)|
|Replied||JHU's Breast Center Reply|
|11/1/2005||gee, the doctor really has to decide this one for you. great news though that things are showing improvement. congrats.|
Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.